Galvanize Therapeutics

Galvanize Therapeutics is an energy-based medical device technology that provides therapeutic products and services to deliver healthcare solutions. The company aims to become the global leader in delivering medical technology innovations that drive biological processes to treat a range of diseases, starting with treating chronic bronchitis symptoms, cardiac arrhythmias, and solid tumors.

It was formed by Apple Tree Partners in 2022.

Galvanize Therapeutics headquartered in United States, North America, operates in the Health Care, Medical, Medical Device, Therapeutics sector. The company focuses on Health Care and has secured $9.5B in funding across 64 round(s). With a team of 51-100 employees, Galvanize Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series B - Galvanize Therapeutics, raised $100.0M. Discover more about their projects, partnerships, and impact on our platform.